This monumental scientific achievement occurred within a context of intense international collaboration, rapid technical ...
HLX's robotics and well-intervention asset utilizations will likely stay strong in Q3 and 2023. Its Q700 (well intervention vessel) has sufficient work in Australia, West Africa, and Brazil in 2023 ...
Helix BioPharma announces positive phase II clinical results with its Topical Interferon Alpha-2b AURORA, ON, March 30 - Helix BioPharma Corp. Helix today announced positive results from its phase II ...
Helix Energy plans to focus on the expanding market of operating and managing well abandonment works. The company's key well intervention vessels are under the spot rate, but they have contracted work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results